Boston Scientific wins Farapulse PFA approval in Japan
September 27, 2024
Boston Scientific (NYSE: BSX)+
continues to expand the reach of its Farapulse pulsed field ablation system for treating atrial fibrillation
Boston Scientific (NYSE: BSX)+
continues to expand the reach of its Farapulse pulsed field ablation system for treating atrial fibrillation
The IV dislodgement-prevention device is now approved for use with blood or blood product transfusions.
The ZEISS MICOR 700 uses the ZEISS NULEX (non-ultrasonic lens extraction) procedure to help surgeons broaden their intraocular working space.